Basel Medical Group (BMGL) Stock Price

Basel Medical Group Price

CLOSED
5.18
​
Market closed

Over the last 3 years Basel Medical Group grew revenue by 2.0% annually, reaching 11.32 M SGD. Earnings per share have grown at 2.4% per year over the last 2 years. For Basel Medical Group, the net margin of -106.8% is down versus 18.6% a few years ago.

Basel Medical Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Basel Medical Group business model & stock analysis

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Ltd. The company provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, and more. Its services include orthopedic treatments and surgery, rehabilitative therapy, and neurosurgical care. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments to complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes.

Frequently asked questions about Basel Medical Group

Converted at the current exchange rate, the Basel Medical Group share trades at 3.61 EUR (5.18 SGD).

The revenue cannot currently be calculated for Basel Medical Group.

The profit cannot currently be calculated for Basel Medical Group.

The P/E ratio cannot be calculated for Basel Medical Group at the moment.

The P/S cannot be calculated for Basel Medical Group currently.

The Eulerpool Quality Score for Basel Medical Group is 1/10.

The ISIN of Basel Medical Group is VGG0864B1031. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Basel Medical Group is BMGL. The ticker symbol is used to trade Basel Medical Group shares on the stock exchange.

Fair ValueTerminal
5.23 SGD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
SGD
Initial public offering
Feb 25, 2025
ISIN
VGG0864B1031
Cusip
G0864B103
Market capitalization
97.36 M SGDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
364.65
P/B Ratio
20.03
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-145.98 %
Last updated Oct 20, 2026, 12:07 PM

Basel Medical Group Peer Group